Alzheon is a U.S. clinical-stage biopharmaceutical company based in Framingham, Massachusetts. The company is developing medicines for patients suffering from Alzheimer's disease and other neurological and psychiatric disorders.

Property Value
dbo:abstract
  • Alzheon is a U.S. clinical-stage biopharmaceutical company based in Framingham, Massachusetts. The company is developing medicines for patients suffering from Alzheimer's disease and other neurological and psychiatric disorders. (en)
dbo:industry
dbo:keyPerson
dbo:location
dbo:wikiPageEditLink
dbo:wikiPageExternalLink
dbo:wikiPageExtracted
  • 2019-06-07 14:19:49Z (xsd:date)
dbo:wikiPageHistoryLink
dbo:wikiPageID
  • 54318778 (xsd:integer)
dbo:wikiPageLength
  • 5697 (xsd:integer)
dbo:wikiPageModified
  • 2019-02-16 22:44:14Z (xsd:date)
dbo:wikiPageOutDegree
  • 21 (xsd:integer)
dbo:wikiPageRevisionID
  • 883682765 (xsd:integer)
dbo:wikiPageRevisionLink
dbp:wikiPageUsesTemplate
dct:subject
rdf:type
rdfs:comment
  • Alzheon is a U.S. clinical-stage biopharmaceutical company based in Framingham, Massachusetts. The company is developing medicines for patients suffering from Alzheimer's disease and other neurological and psychiatric disorders. (en)
rdfs:label
  • Alzheon (en)
foaf:homepage
foaf:isPrimaryTopicOf
foaf:name
  • (en)
  • Alzheon (en)
owl:sameAs
is foaf:primaryTopic of